Africa (WHO region) vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Georgia
100.0%
in 2024
Africa (WHO region) rank
2nd
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Georgia
How they compare
Georgia currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 21 shared years of data; in 2004 it was Georgia ahead.
Africa (WHO region) ranks 2nd and Georgia ranks 1st of 11 groups.
Georgia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.2% | 76.5% | 42.3% | Georgia |
| 2010s | 74.3% | 89.8% | 15.5% | Georgia |
| 2020s | 93.2% | 96.6% | 3.4% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Georgia?
- Georgia, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Georgia?
- 4.0%, with Georgia ahead.
- How many years of comparable data are there for Africa (WHO region) and Georgia?
- 21 years are reported by both, from 2004 to 2024.
- How do Africa (WHO region) and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Georgia ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.